Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

作者: Stuart M. Lichtman , Philip Schulman , Vincent P. Vinciguerra , Kanti R. Rai , Manlio Ferrarini

DOI: 10.1182/BLOOD.V94.6.1840

关键词:

摘要: Cellular immunophenotypic studies were performed on a cohort of randomly selected IgM(+) B-chronic lymphocytic leukemia (B-CLL) cases for which Ig V(H) and V(L) gene sequences available. The categorized based V mutation status CD38 expression analyzed treatment history survival. B-CLL could be divided into 2 groups. Those patients with unmutated genes displayed higher percentages CD38(+) cells (>/=30%) than those mutated that had lower ( /=30% groups responded poorly to continuous multiregimen chemotherapy (including fludarabine) shorter In contrast, the groups, marked male predominance was found. Thus, appear accurate predictors clinical outcome in patients. These parameters, especially can conveniently most laboratories, should valuable adjuncts present staging systems predicting course individual cases. Future evaluations new therapeutic strategies drugs take account different natural histories these manners.

参考文章(40)
Bertold Emmerich, Dagmar Adorf, Christoph Nerl, Michael Hallek, Raymonde Busch, Wolfgang Knauf, Eckhard Thiel, Ingrid Kuhn-Hallek, Marianne Ostwald, Irmgard Langenmayer, Hermann Dietzfelbinger, Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood. ,vol. 93, pp. 1732- 1737 ,(1999) , 10.1182/BLOOD.V93.5.1732
KR Rai, A Sawitsky, EP Cronkite, AD Chanana, RN Levy, BS Pasternack, Clinical staging of chronic lymphocytic leukemia. Blood. ,vol. 46, pp. 219- 234 ,(1975) , 10.1182/BLOOD.V46.2.219.219
Kanti R. Rai, Chronic lymphocytic leukemia in the elderly population Clinics in Geriatric Medicine. ,vol. 13, pp. 245- 249 ,(1997) , 10.1016/S0749-0690(18)30167-8
M Sarfati, S Chevret, C Chastang, G Biron, P Stryckmans, G Delespesse, JL Binet, H Merle-Beral, D Bron, Prognostic Importance of Serum Soluble CD23 Level in Chronic Lymphocytic Leukemia Blood. ,vol. 88, pp. 4259- 4264 ,(1996) , 10.1182/BLOOD.V88.11.4259.4259
Terry J. Hamblin, Zadie Davis, Anne Gardiner, David G. Oscier, Freda K. Stevenson, Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. ,vol. 94, pp. 1848- 1854 ,(1999) , 10.1182/BLOOD.V94.6.1848
C Rozman, E Montserrat, JM Rodriguez-Fernandez, R Ayats, T Vallespi, R Parody, A Rios, D Prados, M Morey, F Gomis, None, Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood. ,vol. 64, pp. 642- 648 ,(1984) , 10.1182/BLOOD.V64.3.642.642
D. Catovsky, J. Fooks, S. Richards, Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival British Journal of Haematology. ,vol. 72, pp. 141- 149 ,(1989) , 10.1111/J.1365-2141.1989.TB07674.X
K Sugita, M P Beckmann, S F Schlossman, T Kobata, G J Freeman, C Morimoto, K Agematsu, Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. Journal of Immunology. ,vol. 153, pp. 1421- 1429 ,(1994)